Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2012
08/02/2012WO2012027365A3 Targeted multi-epitope dosage forms for induction of an immune response to antigens
08/02/2012WO2012006624A3 Factor ix polypeptides and methods of use thereof
08/02/2012WO2011146527A3 Mammalian genes involved in infection
08/02/2012WO2011137245A3 Lytic-peptide-her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of use
08/02/2012WO2010110838A3 Antibody constant domain regions and uses thereof
08/02/2012US20120197114 Nanocarriers for imaging and therapy applications
08/02/2012US20120197059 Ubiquitin interacting motif peptides as cancer therapeutics
08/02/2012US20120196371 Multi plasmids system for the production of influenza virus
08/02/2012US20120195967 Silk-based drug delivery system
08/02/2012US20120195962 Multiepitope Vaccine for Her2/Neu-Associated Cancers
08/02/2012US20120195947 Protein nanocarriers for topical delivery
08/02/2012US20120195943 Bone delivery device
08/02/2012US20120195937 Polyanionic polymer adjuvants for haemophilus influenzae b saccharide vaccines
08/02/2012US20120195932 Geodate delivery vehicles
08/02/2012US20120195928 Vaccines and methods for using the same
08/02/2012US20120195927 Gm-negative ehv-mutants without heterologous elements
08/02/2012US20120195926 Methods of improving vaccine immunogenicity
08/02/2012US20120195925 Vaccines with increased immunogenicity and methods for obtaining them
08/02/2012US20120195924 Adenoviral vector vaccine
08/02/2012US20120195922 Methods for preparing complex multivalent immunogenic conjugates
08/02/2012US20120195921 Recombinant t-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
08/02/2012US20120195920 Staphylococcus aureus div1b for use as vaccine
08/02/2012US20120195919 Hybrid and tandem expression of neisserial proteins
08/02/2012US20120195918 Method of treating cancer with an hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same
08/02/2012US20120195917 Vaccine Composition Comprising 5'-CAP Modified RNA
08/02/2012US20120195916 Method of treating cancer by inhibiting trim59 expression or activity
08/02/2012US20120195915 IAP BIR domain binding compounds
08/02/2012US20120195914 Aldosterone induced elastin production
08/02/2012US20120195913 Compositions and methods of use for therapeutic antibodies
08/02/2012US20120195912 Cripto Blocking Antibodies and Uses Thereof
08/02/2012US20120195911 Method of treatment of cancer patients
08/02/2012US20120195910 Anti-pcsk9 antibodies and methods of use
08/02/2012US20120195909 Antibodies against a proliferating inducing ligand (april)
08/02/2012US20120195908 Combinatorial therapy
08/02/2012US20120195907 Monoclonal antibodies against the pbp2-a protein and homologous sequences for the treatment of infections by and immunodiagnostics of bacteria of the firmicutes phylum
08/02/2012US20120195906 Method for diagnosing and treating emphysema
08/02/2012US20120195905 Targeted binding agents directed to dll4 and uses thereof 524
08/02/2012US20120195904 METHOD TO TREAT USING ANTAGONISTIC ANTI-hTNFSF13B HUMAN ANTIBODIES
08/02/2012US20120195903 Method for the production of antibodies
08/02/2012US20120195902 Compositions and methods for treating renal disease
08/02/2012US20120195901 Compositions and Methods for Binding Lysophosphatidic Acid
08/02/2012US20120195900 Tri-variable domain binding proteins and uses thereof
08/02/2012US20120195899 Immunizing Compositions and Methods of Use
08/02/2012US20120195898 Immunizing Compositions and Methods of Use
08/02/2012US20120195897 Human domain antibodies against components of the human insulin-like growth factor (igf) system
08/02/2012US20120195896 Igf-1 fusion polypeptides and therapeutic uses thereof
08/02/2012US20120195895 Fusion Protein of an Anti-CD20 Antibody Fab Fragment and Lidamycin, a Method for Preparing the Same, and the Use Thereof
08/02/2012US20120195894 Regulatory t cell mediator proteins and uses thereof
08/02/2012US20120195893 TH1/TH2 polarizing vaccines
08/02/2012US20120195892 Immunoglobulin molecules with improved characteristics
08/02/2012US20120195891 Methods, compositions, and kits for treating shiga toxin associated conditions
08/02/2012US20120195890 Oligonucleotides inhibiting cellular migration
08/02/2012US20120195889 Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
08/02/2012US20120195888 Humanized Antibodies Against Human Interferon-Alpha
08/02/2012US20120195887 Inhibitor Compounds and Cancer Treatment Methods
08/02/2012US20120195886 Sodium pump antibody agonists and methods of treating heart disease using the same
08/02/2012US20120195885 Compositions containing glycosylated antibodies and uses thereof
08/02/2012US20120195884 Methods and products for evaluating an immune response to a therapeutic protein
08/02/2012US20120195883 Monocot seed product comprising a human blood protein
08/02/2012US20120195882 lipoparticle comprising a protein and methods of making and using the same
08/02/2012US20120195881 Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions and their use
08/02/2012US20120195880 Modulation of Synaptic Maintenance
08/02/2012US20120195879 Carrier immunoglobulins and uses thereof
08/02/2012US20120195858 Responsiveness to angiogenesis inhibitors
08/02/2012US20120195856 Method of treating patients with cardiovascular illness
08/02/2012US20120195855 Methods for up-regulating antigen expression in tumors
08/02/2012US20120195854 Granulysin in immunotherapy
08/02/2012US20120195852 Vaccines, immunotherapeutics and methods for using the same
08/02/2012US20120195851 Modified soluble fgf receptor fc fusions with improved biological activity
08/02/2012US20120195831 Generation, characterization and uses thereof of anti-her3 antibodies
08/02/2012US20120195830 Monoclonal Antibodies Against Claudin-18 For Treatment of Cancer
08/02/2012US20120195829 Methods for identifying targeting domains and method and compositions comprising the same
08/02/2012CA2825778A1 Pharmaceutical compositions comprising human antibodies to pcsk9
08/02/2012CA2825573A1 Humanized anit-egfr antibody l4-h3 and coding gene thereof
08/02/2012CA2825552A1 Engineering of immunoglobulin domains
08/02/2012CA2825470A1 Cyaa-carried polypeptide(s) and use to induce both therapeutic and prophylactic immune responses
08/02/2012CA2825403A1 Combination vaccines
08/02/2012CA2825255A1 Antibodies selective for cells presenting egfr at high density
08/02/2012CA2825032A1 Advanced prime and boost vaccine
08/01/2012EP2481819A1 Cross flow filtration in the production of stabilized influenza vaccine compositions
08/01/2012EP2481802A2 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes
08/01/2012EP2481757A1 Treatment of multiple sclerosis and/or rheumatoid arthritis
08/01/2012EP2481755A1 Antibody capable of recognizing hla class i
08/01/2012EP2481754A1 Specific binding proteins and uses thereof
08/01/2012EP2481753A1 Anti-IL-17 Antibodies
08/01/2012EP2481752A1 Modified antibody constant regions
08/01/2012EP2481748A2 Foxp3 peptide vaccine
08/01/2012EP2481425A1 Toll like receptor 3 antagonists, methods and uses
08/01/2012EP2481424A1 Improvements in or relating to treatment and prevention of hepatitis C viral infections
08/01/2012EP2481423A1 Novel glycolipid adjuvant compositions
08/01/2012EP2481422A2 Multiplex vaccines
08/01/2012EP2481421A1 Prevention and treatment of sub-clinical pcvd
08/01/2012EP2481420A1 Single dose anti-PCV2 pig vaccine
08/01/2012EP2481419A2 Neisserial vaccines
08/01/2012EP2481418A1 A method for enhancing T cell response
08/01/2012EP2481405A1 Nanoparticles of paclitaxel and albumin in combination with bevacizumab against cancer
08/01/2012EP2481401A1 Lipophilic microparticles containing a protein drug or antigen and formulation comprising same
08/01/2012EP2480687A1 Methods and compositions for the diagnosis and treatment of thyroid cancer
08/01/2012EP2480665A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof
08/01/2012EP2480562A2 Identification of antigenic peptides from multiple myeloma cells
1 ... 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 ... 1823